Vericel (VCEL) Total Debt (QoQ) (2011 - 2018)
Vericel (VCEL) Total Debt (QoQ) (2011 - 2018) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Vericel |
2.04 Bn |
1.90 Bn |
49.27 Mn |
| Date | Value |
|---|
| Sep 30, 2018 |
-23.64% |
| Jun 30, 2018 |
0.10% |
| Mar 31, 2018 |
-3.66% |
| Dec 31, 2017 |
106.51% |
| Sep 30, 2017 |
5.09% |
| Jun 30, 2017 |
-18.53% |
| Mar 31, 2017 |
1,148.46% |
| Dec 31, 2016 |
15.86% |
| Sep 30, 2016 |
1,246.15% |
| Jun 30, 2016 |
-16.13% |
| Mar 31, 2016 |
-12.68% |
| Dec 31, 2015 |
-12.35% |
| Sep 30, 2015 |
-10.99% |
| Jun 30, 2015 |
-9.00% |
| Mar 31, 2015 |
-78.12% |
| Dec 31, 2014 |
198.69% |
| Sep 30, 2014 |
-93.88% |
| Jun 30, 2014 |
124,900.00% |
| Mar 31, 2014 |
-66.67% |
| Dec 31, 2013 |
-40.00% |
